Newsroom

PHOENIX--(BUSINESS WIRE)--Second verse, same as the first. The Dallas-Fort Worth-Arlington metropolitan area once again takes top honors as the No. 1 U-Haul growth metro, replicating its 2024 honor with the greatest net gain of one-way customers during 2025. Likewise, the city proper of Ocala, Fla., retains the title of No. 1 U-Haul growth city, a distinction it also held for 2024 and 2022. Metros: Texas stronghold Texas metros litter the latest U-Haul Growth Index, claiming the top three spots...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Global Water UCITS ETF 05.01.2026 H2O LN IE000Q8F0M81 550,002.00 USD 11,088,645.54 20.161  ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Brett P. Monia, Ph.D., chief executive officer, will present a company overview at the 44th Annual J.P. Morgan Healthcare Conference at 8:15 a.m. PT on Tuesday, January 13, 2026. A live webcast of the presentation can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events. A replay will be available on the Ionis website within 48 hours and will be arch...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NBC Global Finance Limited LEI: 549300KWU8YQOYSK5Y64 (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and...

LONDON--(BUSINESS WIRE)--Valuedynamx, a leading provider of purchase rewards, today announced a strategic partnership with Radisson Hotel Group to expand its Radisson Rewards loyalty program. Now, more than 25 million Radisson Rewards members across the UK, India, France, Germany, USA, Spain and Italy, will be able to earn points on everyday purchases made online through the new Radisson Rewards Shop. This expansion allows members to accelerate their path to hotel stays and access the full rang...

SEATTLE--(BUSINESS WIRE)--Claire J. Alexander, the respected operations strategist and trusted advisor behind some of the financial services industry’s most aggressive AUM expansion arcs — including assisting advisors in scaling firms from $100M to $3.5B in just three years — has announced The Billion Dollar Firm Trifecta Masterclass. This exclusive intensive is designed for financial advisory leaders navigating the complexity that comes with accelerated firm expansion. The Billion Dollar Firm...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - October 05.01.2026 FOCT.LN IE0004X8KUG5 50,002.00 USD 1,370,936.31 27.418  ...

OTTAWA, Ontario & SANTA CLARA, Calif.--(BUSINESS WIRE)--Edgewater Wireless Systems Inc. (TSXV: YFI) (OTC: KPIFF), the industry pioneer of AI-powered Wi-Fi Spectrum Slicing™ technology for residential, enterprise and Industrial IoT markets, today announced that it has selected Synopsys (NASDAQ: SNPS) as a core vendor in its next-generation Wi-Fi8-ready spectrum slicing silicon program. The market pull for reliability-first Wi‑Fi is accelerating. Analyst forecasts project the global Wi‑Fi chipset...

DALLAS--(BUSINESS WIRE)--Sunoco LP (NYSE: SUN) (“Sunoco” or the “Partnership”) today announced its 2026 guidance. Sunoco’s 2026 Guidance Full-year 2026 Adjusted EBITDA(1)(2) to be in the range of $3.1 billion to $3.3 billion, which includes the following assumptions: Total Parkland synergies of approximately $125 million Planned 50-day maintenance turnaround at Burnaby Refinery beginning at the end of January Closing of the TanQuid acquisition in the first quarter of 2026 Growth capital expendi...

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today announces the company’s key priorities and anticipated catalysts for 2026. “Following another year of strong execution across our portfolio, we enter 2026 positioned for meaningful value-creation and progress,” said Steve Mahoney, President and Chief Executive Officer of...